Skip to main content

Advertisement

Table 2 EULAR response in function of the number of previously failed anti-TNFs

From: The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

Number of previously failed anti-TNFs EULAR response at week 16
  No response Moderate response Good response
1 (n = 99) 13.1% 59.6% 27.3%
2 (n = 72) 18.1% 58.3% 23.6%
3 (n = 31) 32.3% 51.6% 16.1%
  1. EULAR, European League Against Rheumatism; TNF, tumor necrosis factor.